Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Northwestern University Chicago, Illinois, USA.
J Womens Health (Larchmt). 2023 Jun;32(6):652-656. doi: 10.1089/jwh.2022.0409. Epub 2023 Apr 20.
Professional guidelines and state law require screening for sexually transmitted infections (STI) during pregnancy. Our objective was to evaluate adherence to these recommendations. This is a retrospective cohort study of patients initiating prenatal care before 20 weeks' gestation. Demographic characteristics and STI screening were abstracted from prenatal records. Tests of interest included initial syphilis, human immunodeficiency virus (HIV), hepatitis B, chlamydia, and gonorrhea tests, as well as repeat (third trimester) syphilis and HIV tests. All patients were eligible for initial screening. Patients were eligible for analysis of whether they received adherent repeat third trimester screening for syphilis (mandated by state law) and HIV (institutional protocol) if they delivered at or after 32 weeks' gestation. Adherent screening was defined as performance of all recommended screening. Of 2370 patients, 1816 (76.6%) received adherent initial STI screening and 181 (7.8% of 2308 patients who delivered at or after 32 weeks' gestation) received adherent repeat third trimester STI screening. After adjusting for covariates, private insurance (adjusted odds ratio [aOR] 1.45, confidence interval [95% CI] 1.12-1.95) was associated with adherent initial screening, whereas being non-Hispanic Black or Hispanic were associated with lower odds of adherent initial screening. Factors associated with adherent repeat third trimester STI screening were younger age (aOR 0.93, 95% CI 0.90-0.97) and non-Hispanic Black race (aOR 3.24, 95% CI 1.94-5.42). Those with private insurance (aOR 0.10, 95% CI 0.06-0.15) were less likely to receive adherent repeat third trimester screening. STI screening rates remain suboptimal. Multiple disparities exist in performance both of initial and repeat third trimester screening.
专业指南和州法律要求在怀孕期间筛查性传播感染(STI)。我们的目的是评估对这些建议的遵守情况。这是一项对 20 周妊娠前开始产前护理的患者进行的回顾性队列研究。从产前记录中提取人口统计学特征和 STI 筛查信息。感兴趣的测试包括初始梅毒、人类免疫缺陷病毒(HIV)、乙型肝炎、衣原体和淋病测试,以及重复(第三 trimester)梅毒和 HIV 测试。所有患者均有资格进行初始筛查。如果患者在 32 周或之后分娩,则有资格接受是否接受了适当的重复第三 trimester 梅毒(州法律要求)和 HIV(机构方案)筛查。依从性筛查定义为所有推荐筛查的实施。在 2370 名患者中,1816 名(76.6%)接受了依从性初始 STI 筛查,181 名(2308 名在 32 周或之后分娩的患者中的 7.8%)接受了依从性重复第三 trimester STI 筛查。在调整了混杂因素后,私人保险(调整后的优势比[aOR] 1.45,95%置信区间[95%CI] 1.12-1.95)与依从性初始筛查相关,而非西班牙裔黑人或西班牙裔与较低的依从性初始筛查几率相关。与依从性重复第三 trimester STI 筛查相关的因素是年龄较小(aOR 0.93,95%CI 0.90-0.97)和非西班牙裔黑人种族(aOR 3.24,95%CI 1.94-5.42)。那些有私人保险的人(aOR 0.10,95%CI 0.06-0.15)不太可能接受依从性重复第三 trimester 筛查。STI 筛查率仍然不理想。在初始和重复第三 trimester 筛查的表现上都存在多种差异。